Article

Integrin α6β4 signaling switches DNA repair from homologous recombination to…

medRxiv · 2019 · Chen, M.; Marrs, B.; Qi, L.; Knifley, T.; Jarrett, S.; Weiss, H. L.; Stewart, R. L.; D'Orazio, J. A.; O'Connor, K. L.

Key facts

Title Integrin α6β4 signaling switches DNA repair from homologous recombination to non-homologous end-joining pathway to sensitize breast cancer cells to cisplatin
First author Chen, M.; Marrs, B.; Qi, L.; Knifley, T.; Jarrett, S.; Weiss, H. L.; Stewart, R. L.; D'Orazio, J. A.; O'Connor, K. L.
Journal medRxiv
Published Oct 1, 2019
DOI 10.1101/785873
Devices mentioned BK110039, DEN000008, K022086
Product codes mentioned JCI, KIT, NDS, NJT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature